Hubbry Logo
Poly(amidoamine)Poly(amidoamine)Main
Open search
Poly(amidoamine)
Community hub
Poly(amidoamine)
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
Poly(amidoamine)
Poly(amidoamine)
Poly(amidoamine)
View on Wikipedia
from Wikipedia

Poly(amidoamine), or PAMAM, is a class of dendrimer which is made of repetitively branched subunits of amide and amine functionality. PAMAM dendrimers, sometimes referred to by the trade name Starburst, have been extensively studied since their synthesis in 1985,[1] and represent the most well-characterized dendrimer family as well as the first to be commercialized.[2] Like other dendrimers, PAMAMs have a sphere-like shape overall, and are typified by an internal molecular architecture consisting of tree-like branching, with each outward 'layer', or generation, containing exponentially more branching points. This branched architecture distinguishes PAMAMs and other dendrimers from traditional polymers, as it allows for low polydispersity and a high level of structural control during synthesis, and gives rise to a large number of surface sites relative to the total molecular volume. Moreover, PAMAM dendrimers exhibit greater biocompatibility than other dendrimer families, perhaps due to the combination of surface amines and interior amide bonds; these bonding motifs are highly reminiscent of innate biological chemistry and endow PAMAM dendrimers with properties similar to that of globular proteins.[2] The relative ease/low cost of synthesis of PAMAM dendrimers (especially relative to similarly-sized biological molecules such as proteins and antibodies), along with their biocompatibility, structural control, and functionalizability, have made PAMAMs viable candidates for application in drug development, biochemistry, and nanotechnology.[2][3][4]

Synthesis

[edit]

Divergent synthesis

[edit]
A general scheme for the divergent synthesis of PAMAM dendrimers, with ethylene diamine as a core initiator. The scheme is color-coded by generation number, with the red ethylene diamine core serving as initiator core, orange as Generation 0 and orange/green as Generations 1, respectively. The scheme shown is currently the most widely adopted approach in commercial syntheses of PAMAM. Note: In this picture there is a small error as there is an oxigen atom to much in the first generation of the PAMAM. [5]

Divergent synthesis refers to the sequential "growth" of a dendrimer layer by layer, starting with a core "initiator" molecule which contains functional groups capable of acting as active sites in the initial reaction. Each subsequent reaction in the series increases the number of available surface groups exponentially. Core molecules which give rise to PAMAM dendrimers can vary, but the most basic initiators are ammonia and ethylene diamine.[6] Outward growth of PAMAM dendrimers is accomplished by alternating between two reactions:

  1. Michael addition of the amino-terminated surface onto methyl acrylate, resulting in an ester-terminated outer layer, and
  2. Coupling with ethylene diamine to achieve a new amino-terminated surface.

Each round of reactions forms a new "generation", and PAMAM dendrimers are often classified by generation number; the common shorthand for this classification is "GX" or "GX PAMAM", where X is a number referring to the generation number. The first full cycle of Michael addition followed by coupling with ethylene diamine forms Generation 0 PAMAM, with subsequent Michael additions giving rise to "half" generations, and subsequent amide coupling giving rise to "full" (integer) generations.

With divergent synthesis of dendrimers, it is extremely important to allow each reaction to proceed to completion; any defects caused by incomplete reaction or intramolecular coupling of new surface amines with unreacted methyl ester surface groups could cause "trailing" generations, stunting further growth for certain branches. These impurities are difficult to remove when using the divergent synthetic approach because the molecular weight, physical size, and chemical properties of the defective dendrimers are very similar in nature to the desired product. As generation number increases, it becomes more difficult to produce pure products in a timely fashion due to steric constraints. As a result, synthesis of higher-generation PAMAM dendrimers can take months.

Convergent synthesis

[edit]

Convergent synthesis of a dendrimer begins with what will eventually become the surface of the dendrimer and proceeds inward. The convergent synthetic approach makes use of orthogonal protecting groups (two protecting groups whose deprotection conditions will not remove one another); this is an additional consideration not present when using a divergent approach. The figure below depicts a general scheme for a convergent synthetic approach.

A generalized scheme outlining the use of orthogonal protecting groups for convergent synthesis of PAMAM dendrimers.

Convergent synthesis as shown above begins with the dendritic subunit composed of reactive "focal group" A and branched group B (B can be multiply branched in the most generalized scenario, but PAMAMs only split once at each branching point). First, A is orthogonally protected and set aside for further reactions. B is also orthogonally protected, leaving the unprotected A on this molecule to couple with each of the unprotected B groups from the initial compound. This results in a new higher-generation species that is protected on both A and B. Selective deprotection of A yields a new molecule which can again be coupled onto the original monomer, thus forming another new generation. This process can then be repeated to form more and more layers.

  • Note that the black protecting groups for group B represent what will become the outermost layer of the final molecule, and remain attached throughout the synthetic process; their purpose is to guarantee that propagation of dendrimer growth can take place in a controlled fashion by preventing unwanted side reactions.
  • In forming each new layer, the number of AB couplings is restricted to two, in sharp contrast to the divergent synthetic approach, which involves exponentially more couplings per layer.
  • Incomplete reaction products (single addition adduct, unreacted starting materials) will have a markedly different molecular weight from the desired product, especially for higher-generation compounds, making purification more straightforward.
  • The reactive focal group A must be terminated onto a final acceptor at some point during the synthetic process; until then, each compound can only be considered a dendron and not a full dendrimer (see page for disambiguation).
  • An advantage to synthesizing dendrons with focal group A as a chemical handle is the ability to attach multiple equivalents of the dendron to a polyfunctional core molecule; changing the core element does not require rebuilding the entire dendrimer. In the case of PAMAM, the focal points of convergently synthesized fragments have been used to create unsymmetrical dendrimers [7] as well as dendrimers with various core functionalization.[8]
  • Since each successive generation of dendron becomes bulkier, with final attachment to the dendrimer core being the most prohibitive step of all, steric constraints can severely impact yield.

Toxicity

[edit]

in vitro

[edit]

It has been established that cationic macromolecules in general destabilize the cell membrane, which can lead to lysis and cell death.[9] The common conclusion present in current work echoes this observation: increasing dendrimer molecular weight and surface charge (both being generation-dependent) increases their cytotoxic behavior.[10][11][12][13][14][15]

Initial studies on PAMAM toxicity showed that PAMAM was less toxic (in some cases, much less so) than related dendrimers,[16] exhibiting minimal cytotoxicity across multiple toxicity screens, including tests of metabolic activity (MTT assay), cell breakdown (LDH assay), and nucleus morphology (DAPI staining).[10] However, in other cell lines, the MTT assay and several other assays revealed some cytotoxicity.[12][13] These disparate observations could be due to differences in sensitivity of the various cell lines used in each study to PAMAM; although cytotoxicity for PAMAM varies among cell lines, they remain less toxic than other dendrimer families overall.

More recently, a series of studies by Mukherjee et al.[13][14][15] have shed some light on the mechanism of PAMAM cytotoxicity, providing evidence that the dendrimers break free of their encapsulating membrane (endosome) after being absorbed by the cell, causing harm to the cell's mitochondria and eventually leading to cell death. Further elucidation of the mechanism of PAMAM cytotoxicity would help resolve the dispute as to precisely how toxic the dendrimers are.

In relation to neuronal toxicity, fourth generation PAMAM has been shown to break down calcium transients, altering neurotransmitter vesicle dynamics and synaptic transmission. All of the above can be prevented by replacing the surface amines with folate or polyethylene glycol.[17]

It has also been shown that PAMAM dendrimers cause rupturing of red blood cells, or hemolysis.[12] Thus, if PAMAM dendrimers are to be considered in biological applications that involve dendrimers or dendrimer complexes traveling through the bloodstream, the concentration and generation number of unmodified PAMAM in the bloodstream should be taken into account.

in vivo

[edit]

To date, few in-depth studies on the in vivo behavior of PAMAM dendrimers have been carried out. This could be in part due to the diverse behavior of PAMAMs depending on surface modification (see below), which make characterization of their in vivo properties largely case-dependent. Nonetheless, the fate and transport of unmodified PAMAM dendrimers is an important case study as any biological applications could involve unmodified PAMAM as a metabolic byproduct. In the only major systematic study of in vivo PAMAM behavior, injections of high levels of bare PAMAMs over extended periods of time in mice showed no evidence of toxicity up through G5 PAMAM, and for G3-G7 PAMAM, low immunogenicity was observed.[11] These systemic-level observations seem to align with the observation that PAMAM dendrimers are not extremely cytotoxic overall; however, more in-depth studies of the pharmacokinetics and biodistribution of PAMAM are required before a move toward in vivo applications can be made.

Surface modification

[edit]

One unique property of dendrimers such as PAMAM is the high density of surface functional groups, which allow many alterations to be made to the surface of each dendrimer molecule. In putative PAMAM dendrimers, the surface is rife with primary amines, with higher generations expressing exponentially greater densities of amino groups. Although the potential to attach many things to each dendrimer is one of their greatest advantages, the presence of highly localized positive charges can be toxic to cells. Surface modification via attachment of acetyl[18] and lauroyl[19] groups help mask these positive charges, attenuating cytotoxicity and increasing permeability to cells. Thus, these types of modifications are especially beneficial for biological applications. Secondary and tertiary amino surface groups are also found to be less toxic than primary amino surface groups,[10] suggesting it is charge shielding which has major bearing on cytotoxicity and not some secondary effect from a particular functional group. Furthermore, other studies point to a delicate balance in charge which must be achieved to obtain minimal cytotoxicity. Hydrophobic interactions can also cause cell lysis, and PAMAM dendrimers whose surfaces are saturated with nonpolar modifications such as lipids or polyethylene glycol (PEG) suffer from higher cytotoxicity than their partially substituted analogues.[19] PAMAM dendrimers with nonpolar internal components have also been shown to induce hemolysis.[12]

Applications

[edit]

Applications involving dendrimers in general take advantage of either stuffing cargo into the interior of the dendrimer (sometimes referred to as the "dendritic box"), or attaching cargo onto the dendrimer surface. PAMAM dendrimer applications have generally focused on surface modification, taking advantage of both electrostatic and covalent methods for binding cargo. Currently, major areas of study using PAMAM dendrimers and their functionalized derivatives involve drug delivery and gene delivery.

Drug delivery

[edit]

Since PAMAM dendrimers have shown penetration capability to a wide range of cell lines, simple PAMAM-drug complexes would affect a broad spectrum of cells upon introduction to a living system. Thus, additional targeting ligands are required for the selective penetration of cell types. For example, PAMAM derivatized with folic acid is preferentially taken up by cancer cells, which are known to overexpress the folate receptor on their surfaces. Attaching additional treatment methods along with the folic acid, such as boron isotopes,[20] cisplatin,[21] and methotrexate have proven quite effective.[22] In the future, as synthetic control over dendrimer surface chemistry becomes more robust, PAMAM and other dendrimer families may rise to prominence alongside other major approaches to targeted cancer therapy.

In a study of folic acid functionalized PAMAM, methotrexate was combined either as an inclusion complex within the dendrimer or as a covalent surface attachment. In the case of the inclusion complex, the drug was released from the dendrimer interior almost immediately when subjected to biological conditions and acted similarly to the free drug. The surface attachment approach yielded stable, soluble complexes which were able to selectively target cancer cells and did not prematurely release their cargo.[22] Drug release in the case of the inclusion complex could be explained by the protonation of surface and interior amines under biological conditions, leading to unpacking of the dendrimer conformation and consequent release of the inner cargo. A similar phenomenon was observed with complexes of PAMAM and cisplatin.[23]

PAMAM dendrimers have also demonstrated intrinsic drug properties. One quite notable example is the ability for PAMAM dendrimers to remove prion protein aggregates,[24] the deadly protein aggregates responsible for bovine spongiform encephalopathy ("mad cow disease") and Creutzfeldt–Jakob disease in humans. The solubilization of prions is attributed to the polycationic and dendrimeric nature of the PAMAMs, with higher generation (>G3) dendrimers being the most efficient; hydroxy-terminated PAMAMs as well as linear polymers showed little to no effect. Since there are no other known compounds capable of dissolving prions which have already aggregated, PAMAM dendrimers have offered a bit of reprieve in the study of such fatal diseases, and may offer additional insight into the mechanism of prion formation.

Gene therapy

[edit]
Surface amine residues on PAMAM dendrimers bind to the phosphate backbone of nucleic acids through charged interactions (right, inset). Typically, G6-7 PAMAM dendrimers are used for gene transfection; these dendrimers are typically 6-10nm in length (spanning ~20-30 base pairs) and have a molecular mass of 30-50kDa.[25]

The discovery that mediating positive charge on PAMAM dendrimer surfaces decreases their cytotoxicity has interesting implications for DNA transfection applications. Because the cell membrane has a negatively charged exterior, and the DNA phosphate backbone is also negatively charged, the transfection of free DNA is not very efficient simply due to charge repulsion. However, it would be reasonable to expect charged interactions between the anionic phosphate backbone of DNA and the amino-terminated surface groups of PAMAM dendrimers, which are positively ionized under physiological conditions. This could result in a PAMAM-DNA complex, which would make DNA transfection more efficient due to neutralization of the charges on both elements, while the cytotoxicity of the PAMAM dendrimer would also be reduced. Indeed, several reports have confirmed PAMAM dendrimers as effective DNA transfection agents.[16][26][27][28]

When the charge balance between DNA phosphates and PAMAM surface amines is slightly positive, the maximum transfection efficiency is obtained;[23] this finding supports the idea that the complex binds to the cell surface via charge interactions. A striking observation is that "activation" of PAMAM by partial degradation via hydrolysis improves transfection efficiency by 2-3 orders of magnitude,[23] providing further evidence supporting the existence of an electrostatically coupled complex. The fragmentation of some branches of the dendrimer is thought to loosen up the overall structure (fewer amide bonds and space constraints), which would theoretically result in better contact between the dendrimer and DNA substrate because the dendrimer is not forced into a rigid spherical conformation due to sterics. This in turn results in more compact DNA complexes which are more easily endocytosed. After endocytosis, the complexes are subjected to the acidic conditions of the cellular endosome. The PAMAM dendrimers act as a buffer in this environment, soaking up the excess protons with multitudes of amine residues, leading to the inhibition of pH-dependent endosomal nuclease activity and thus protecting the cargo DNA. The tertiary amines on the interior of the dendrimer can also participate in the buffering activity, causing the molecule to puff up; additionally, as the PAMAMs take on more and more positive charge, fewer of them are required for the optimal PAMAM-DNA interaction, and free dendrimers are released from the complex. Dendrimer release and swelling can eventually lyse the endosome, resulting in release of the cargo DNA. The activated PAMAM dendrimers have less spatial barrier to interior amine protonation, which is thought to be a major source of their advantage over non-activated PAMAM.[25]

PAMAM dendrimers can be "activated" for gene transfer applications via hydrolysis accelerated by heat, a process which can be thought of as similar to shearing bushes. During this process, amide bonds are broken and replaced with carboxyl groups (see inset), causing some branches of the dendrimer to fall off. The overall molecular mass of the dendrimer is reduced by 20-25%, and the result is a more flexible dendrimer with transfection efficiencies improved by 2-3 orders of magnitude.[25]

In the context of existing approaches to gene transfer, PAMAM dendrimers hold a strong position relative to major classical technologies such as electroporation, microinjection, and viral methods. Electroporation, which involves pulsing electricity through cells to create holes in the membrane through which DNA can enter, has obvious cytotoxic effects and is not appropriate for in vivo applications. On the other hand, microinjection, the use of fine needles to physically inject genetic material into the cell nucleus, offers more control but is a high-skill, meticulous task in which a relatively low number of cells can be transfected. Although viral vectors can offer highly specific, high-efficiency transfection, the generation of such viruses is costly and time-consuming; furthermore, the inherent viral nature of the gene transfer often triggers an immune response, thus limiting in vivo applications. In fact, many modern transfection technologies are based on artificially assembled liposomes (both liposomes and PAMAMs are positively charged macromolecules).[25] Since PAMAM dendrimers and their complexes with DNA exhibit low cytotoxicity, higher transfection efficiencies than liposome-based methods, and are effective across a broad range of cell lines,[16] they have taken an important place in modern gene therapy methodologies. The biotechnology company Qiagen currently offers two DNA transfection product lines (SuperFect and PolyFect) based on activated PAMAM dendrimer technology.

Much work lies ahead before activated PAMAM dendrimers can be used as in vivo gene therapy agents. Although the dendrimers have proved to be highly efficient and non-toxic in vitro, the stability, behavior, and transport of the transfection complex in biological systems has yet to be characterized and optimized. As with drug delivery applications, specific targeting of the transfection complex is ideal and must be explored as well.

See also

[edit]

References

[edit]

Bibliography

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Poly(amidoamine)

View on Grokipedia
from Grokipedia
Poly(amidoamine) (PAMAM) dendrimers are a class of highly branched, monodisperse synthetic macromolecules featuring a well-defined, tree-like built from repeating amidoamine units that branch iteratively from a central core, such as or . These nanoscale polymers, typically ranging from 1 to 10 nm in diameter depending on their (G0 to G10), possess unparalleled molecular uniformity, narrow molecular weight distributions, and a high of surface functional groups, primarily primary amines, which enable extensive customization. First reported in through a divergent synthesis method involving successive Michael addition of and amidation with , PAMAM dendrimers represent the inaugural complete family of dendrimers to be synthesized, characterized, and commercialized. This iterative process allows precise control over size, shape (spheroidal from G4 onward), and branching, with each generation exponentially increasing the number of surface groups—from 4 in G0 to 4096 in G10—while molecular weights span from approximately 517 Da to 934,720 Da. Their internal structure includes tertiary amines (pKa 3-6) and linkages, contributing to and a cationic surface charge (pKa 8-9) that facilitates interactions with biological molecules. PAMAM dendrimers are renowned for their biocompatibility and versatility in biomedical applications, particularly as nanocarriers for drug and gene delivery. The proton-sponge effect from their amine groups promotes endosomal escape, enhancing the delivery of nucleic acids like DNA, siRNA, and miRNA by forming stable dendriplexes via electrostatic interactions. Surface modifications, such as PEGylation or conjugation with targeting ligands (e.g., folic acid), mitigate potential cytotoxicity associated with higher generations (e.g., G7) and improve tumor targeting through the enhanced permeability and retention (EPR) effect or receptor-mediated endocytosis. Beyond therapeutics, they serve in diagnostics, imaging, and catalysis due to their modifiable interiors for guest molecule encapsulation and high reactivity.

Overview

Definition and Characteristics

Poly(amidoamine) (PAMAM) dendrimers are a class of highly branched, nanoscale, spherical macromolecules characterized by a radially symmetric structure consisting of a central core, iterative branching units, and numerous terminal functional groups. Typically synthesized with an (EDA) core, these dendrimers feature repeating amidoamine monomers that form dendritic branches, resulting in a tree-like with well-defined layers known as generations (G). This composition imparts a monodisperse nature, distinguishing PAMAM from traditional linear or randomly branched polymers. Key characteristics of PAMAM dendrimers include their low polydispersity index (PDI), often below 1.1, which ensures a narrow molecular and precise control over size and shape. Their hydrodynamic is tunable, ranging from approximately 1 nm for lower generations (e.g., G1) to over 10 nm for higher ones (e.g., G10), allowing customization for specific applications. The surface is densely populated with primary groups—numbering up to 4096 for a G10 EDA-core dendrimer—providing sites for further functionalization, while the interior contains void spaces or cavities suitable for hosting guest molecules through encapsulation. Compared to linear polymers of similar molecular weight, PAMAM dendrimers exhibit enhanced , attributed to their globular shape, lower , and reduced entanglement, which minimize nonspecific interactions with biological systems. PAMAM represents the first family to be commercialized, with production beginning in the mid-1990s through licensing of Dow Chemical's patents to Dendritech, Inc., enabling widespread availability for . In , these properties position PAMAM dendrimers as versatile carriers for targeted delivery.

Historical Development

Poly(amidoamine) (PAMAM) dendrimers were invented by Donald A. Tomalia and his team at between 1979 and , marking the first systematic synthesis of a complete family using a divergent approach starting from an or core. The foundational work culminated in the first detailed publication in , which described the preparation and characterization of these starburst-dendritic macromolecules, introducing the term "" and outlining their highly branched, nanoscale architecture. This seminal paper, presented initially at a 1984 , laid the groundwork for understanding PAMAM as monodisperse polymers with predictable generations, supported by early patents such as U.S. Patent 4,507,466 filed in 1983 and issued in . In the early 1990s, commercialization efforts advanced with the establishment of Dendritech, Inc. in 1992 as a spin-off licensed by Dow Chemical to produce and distribute PAMAM dendrimers on a larger scale, enabling their availability for research and initial industrial applications. The 1990s saw a primary focus on perfecting synthesis methods, including iterative Michael addition and amidation steps to achieve higher generations with controlled molecular weights and low polydispersity, as evidenced by structural confirmations via techniques like size-exclusion chromatography. By the 2000s, research shifted toward exploring applications, particularly in , highlighted by a 2001 review by Esfand and Tomalia that emphasized PAMAM's biomimetic properties, such as multivalency and , for and targeting. Post-2010 developments centered on surface modifications to mitigate associated with cationic termini, including and to enhance while preserving encapsulation capabilities, as documented in studies on generation-dependent . A 2022 mini-review by Wang et al. synthesized this evolution, underscoring PAMAM's progression from synthetic novelty to a cornerstone in targeted therapeutics despite ongoing challenges in and . As of 2025, continued advancements include PAMAM-based platforms for tumor CT imaging and theranostics.

Structure and Properties

Molecular Architecture

Poly(amidoamine) (PAMAM) dendrimers possess a distinctive hierarchical, tree-like molecular architecture that defines their core-shell organization, consisting of a central multifunctional core, radially extending branches composed of iterative amido units, and a dense array of surface functional groups. The core is commonly (ED), which provides a branching multiplicity of 4 through its two primary groups each initiating two branches, establishing the foundational and multiplicity of the . This core anchors the dendrimer's overall geometry, enabling the symmetric expansion of branches in a controlled, layered manner. The branching pattern follows a 1→2 motif, where each amine reacts to form two new branches per generation, leading to exponential proliferation of terminal groups and an increasingly complex, globular form. For instance, the zeroth generation (G0) features 4 primary amine termini directly attached to the core, while higher generations amplify this: G1 has 8 amines, G2 has 16, G3 has 32, G4 has 64, and G5 reaches 128 primary amines at the periphery. These branches are constructed from repeating -CH₂CH₂C(O)NHCH₂CH₂N- amidoamine units, which layer outward in concentric shells, creating a radially symmetric, three-dimensional scaffold that resembles a nanoscale tree with iterative forking. Internally, the architecture includes a hydrophilic core-shell domain rich in tertiary amines and amide linkages, forming interconnected nanocavities that facilitate guest molecule entrapment through non-covalent interactions. The surface termini, predominantly primary amines in full-generation PAMAM (e.g., G0 to G10), provide reactive sites for further functionalization, while half-generations (e.g., G0.5) terminate in carboxyl or ester groups, allowing tunable surface chemistry. This generational progression can be illustrated conceptually as starting from the compact G0 core—a small, tetra-amine cluster—expanding outward with each layer: G1 adds short amidoamine arms to form an eight-pronged star, G2 doubles to a 16-fold branched , and so on, culminating in G5 as a densely packed, near-spherical entity with extensive peripheral crowding that reinforces the globular morphology. The presence of protonatable tertiary amines within the branches imparts inherent pH-responsive characteristics to the internal , enabling conformational adjustments that support host-guest dynamics.

Generation-Dependent Properties

The hydrodynamic of poly(amidoamine) (PAMAM) dendrimers increases nearly linearly with generation number, reflecting the progressive addition of branched layers around the core, as determined by (DLS). For instance, amine-terminated G3 PAMAM dendrimers exhibit a diameter of approximately 3.1 nm, while dendrimers reach about 8.1 nm theoretically, with experimental DLS values aligning closely for lower generations. At physiological pH, PAMAM dendrimers display a cationic surface charge arising from the protonation of peripheral amine groups, resulting in zeta potentials typically ranging from +34.6 mV for G4 to +43.3 mV for G3 and G5 amine-terminated variants. Higher generations amplify charge density due to the exponential increase in the number of surface amines (e.g., 32 for G3 versus 128 for G5), enhancing electrostatic interactions while maintaining positive potentials around +40 to +50 mV. PAMAM dendrimers remain -soluble up to generation 10, facilitated by the abundance of polar and functionalities that promote hydrogen bonding with molecules. Beyond G10, steric crowding from densely packed branches reduces solubility, often leading to gel-like aggregates rather than fully dissolved states. Other key properties also vary markedly with generation. Solution rises exponentially with increasing generation, driven by escalating molecular weight and branching density, which impedes chain entanglement and flow compared to linear polymers. Encapsulation capacity, meanwhile, scales with the dendrimer's internal void volume; for example, G5 PAMAM can accommodate several dozen small molecules (e.g., ~20-30 depending on the guest) within its branched interior through non-covalent interactions.

Synthesis

Divergent Synthesis

The divergent synthesis of poly(amidoamine) (PAMAM) dendrimers involves an iterative, outward-branching process starting from a central core molecule, typically (EDA), to construct highly symmetric, branched architectures through successive generations. This method, pioneered by Tomalia and colleagues, relies on two repeating reaction steps: a Michael addition of groups to (MA) to form ester intermediates, followed by amidation of those esters with excess EDA to generate new terminal groups. The process begins with EDA as the initiator core, which possesses two primary groups. In the first step, EDA reacts with three equivalents of MA at 25°C for 48 hours under a atmosphere, yielding a tetra-ester intermediate (generation -0.5 PAMAM). This intermediate is then amidated with excess EDA in at 0°C for 48 hours, producing generation 0 (G0) PAMAM dendrimer with four terminal primary groups. Yields for this G0 formation are typically high, around 90-95%. To advance to the next , the G0 tetramine undergoes Michael addition with four equivalents of MA under similar conditions, forming an octa-ester intermediate ( 0.5 PAMAM). Subsequent amidation with excess EDA converts the esters to amines, resulting in 1 (G1) PAMAM with eight terminal primary amine groups. This two-step is reiterated for higher generations, with each cycle doubling the number of terminal amines and branching points, enabling geometric growth up to 10 or beyond. Yields remain high (around 90-95%) through early generations, supporting for symmetric structures and facilitating commercial production of PAMAM dendrimers up to G10. Purification after each cycle is commonly achieved via to remove unreacted monomers and low-molecular-weight byproducts, ensuring product homogeneity. Despite its effectiveness, the divergent approach introduces minor structural defects due to incomplete reactions or side products like intrabranched cycles. These imperfections accumulate in higher generations, and steric hindrance from dense branching reduces reaction efficiency beyond , leading to lower yields and increased polydispersity. As an alternative for preparing unsymmetric variants with greater control over branching, the convergent synthesis method assembles dendrons inward before attachment to the core.

Convergent Synthesis

The convergent synthesis of poly(amidoamine) (PAMAM) dendrimers constructs dendrons from the periphery inward using amine-protecting groups such as tert-butoxycarbonyl (Boc), followed by the of multiple dendrons to a central core , enabling high precision in structural control and customization. This methodology adapts the general convergent strategy originally developed by Hawker and Fréchet for dendritic polyethers to the PAMAM system, where the focal point of each dendron typically features a or group for subsequent attachment. Key steps begin with the Boc protection of one primary amine on an unsymmetric unit, such as 1,2-propanediamine, designating the protected as the future focal point. The free then undergoes Michael addition with excess to form β-amino branches. The groups are subsequently saponified to carboxylic acids to create branching points for further growth. Iterative cycles involve amide coupling of these carboxylic acids to additional Boc-protected units using coupling agents like , followed by deprotection of the terminal Boc groups to expose new amines for the next iteration, building the dendron outward from the focal point. The resulting dendrons are purified individually, often by , before deprotection or activation of the focal group and attachment to a polyfunctional core (e.g., or pentaerythritol-based) via amide coupling, allowing for unsymmetric or hybrid structures through selective dendron variation. This approach yields dendrimers with fewer structural defects than the divergent method, as the smaller, monodisperse dendrons are easier to characterize and purify at each step, minimizing intramolecular cyclization or truncation errors. It is particularly suited for creating tailored PAMAM variants, such as those with mixed surface functionalities or internal branching for specific applications. Despite these benefits, convergent synthesis suffers from lower overall yields for higher generations (typically limited to G3–G5) owing to steric bulk that impedes efficient of larger dendrons to the core, rendering it less ideal for large-scale production compared to the divergent approach.

Characterization

Analytical Techniques

Poly(amidoamine) (PAMAM) dendrimers require precise analytical techniques to assess their size, morphology, molecular weight, surface functionality, and purity, as these properties directly influence their performance in various applications. These methods enable confirmation of generation-specific characteristics and detection of synthesis imperfections, such as incomplete branching or impurities. Common approaches include scattering techniques for physical dimensions, mass spectrometry and chromatography for mass and polydispersity, spectroscopy for functional group analysis, and purification-based assessments for overall sample quality. Atomic force microscopy (AFM) can also provide surface morphology and height profiles for dendrimers adsorbed on substrates, complementing other methods. For size and morphology, dynamic light scattering (DLS) measures the hydrodynamic radius, which scales with dendrimer generation due to increasing branching. For instance, commercial PAMAM dendrimers exhibit hydrodynamic radii ranging from 1.81 nm for generation 4 (G4) to 4.48 nm for G7 in methanol, reflecting their spherical expansion. Transmission electron microscopy (TEM) complements DLS by providing direct visualization of the dendrimer core and overall architecture, revealing compact, globular structures with minimal aggregation in purified samples. These techniques are particularly valuable for higher generations (G4–G7), where DLS sensitivity improves with larger particle sizes. Molecular weight determination confirms the generational identity and branching completeness of PAMAM dendrimers. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) offers high-resolution analysis for lower generations (G1–G3), accurately resolving peaks such as 1453 Da for G1, though it broadens for G4–G7 due to structural heterogeneity. Gel permeation chromatography (GPC), often using multi-angle light scattering detection, provides polydispersity index (PDI) and weight-average molecular weight (Mw), with values approaching theoretical expectations post-purification; for example, purified G5 PAMAM yields an Mw of approximately 26,200 Da, close to the ideal 28,800 Da, indicating minimal defects. Surface groups, primarily primary amines in amine-terminated PAMAM, are quantified to evaluate charge density and functionalization potential. (NMR) spectroscopy, particularly ¹H NMR, identifies and integrates amine protons (e.g., at ~2.69 ppm for terminal -NH₂), allowing calculation of surface group numbers across generations. further assesses amine accessibility and charge, with purified G5 PAMAM showing 109 primary amines per molecule, up from 96 in unpurified samples, highlighting the impact of defect removal on surface properties. Purity assessment focuses on detecting incomplete branches or low-generation impurities, which can compromise dendrimer uniformity. (HPLC), using reverse-phase C5 columns, separates generational variants and defects, revealing purity levels from ~85% for G2 to ~95% for G7 in commercial samples. Dialysis with appropriate membranes (e.g., 10,000 Da) purifies by removing trailing generations and dimers, reducing PDI from 1.043 to 1.018 for G5 and eliminating smaller incomplete branches. These methods ensure high-fidelity PAMAM for downstream use.

Structural Verification

Structural verification of poly(amidoamine) (PAMAM) dendrimers focuses on confirming the highly branched architecture and identifying any imperfections arising from the iterative synthesis process, ensuring the integrity of dendritic, linear, and terminal units. (NMR) spectroscopy, particularly ¹H and ¹³C NMR, serves as a primary method for branching confirmation by distinguishing and peaks based on their chemical shifts and integration ratios. These spectra reveal distinct signals for protons and carbons in terminal groups (around 2.2-2.4 ppm for ¹H NMR methylene protons adjacent to amines), dendritic units (around 8.2-8.4 ppm for amide NH), and linear branch segments, allowing quantification of the relative proportions of each structural motif. The degree of branching (DB) is calculated from these NMR integrations using the formula DB = (D + T) / (D + T + L), where D represents the number of dendritic units, T the number of terminal units, and L the number of linear units; an ideal fully branched PAMAM dendrimer approaches DB ≈ 1.0, indicating minimal linear defects and maximal hyperbranching. This metric provides a direct measure of architectural perfection, with lower generations (e.g., G0-G2) typically achieving DB > 0.95, while higher generations may show slight deviations due to steric crowding. The approach, originally developed for hyperbranched polymers and adapted for PAMAM, relies on quantitative peak assignments to validate the exponential growth of branches per generation. Defects, such as truncated branches from incomplete amidation or cyclization, are detected using (MS), which identifies lower-molecular-weight species corresponding to missing repeat units; for instance, MS (ESI-MS) or MS (MALDI-MS) reveals defect populations of 8-15% in higher generations like G5, manifesting as peaks shifted by multiples of the Michael addition or amidation mass (e.g., 114 Da for branches). These imperfections accumulate with generational progression due to limitations in the crowded periphery, compromising the monodispersity and void structure. Complementary (SAXS) probes radial density profiles, showing a characteristic decrease in from core to periphery in ideal dendrimers, with deviations indicating uneven branching or void irregularities. Full generational verification employs (SEC) coupled with (MALS), which separates dendrimers by hydrodynamic volume while providing absolute molecular weight and independent of standards; for PAMAM G0-G5, SEC-MALS elugrams show narrow polydispersity indices (<1.05) and generational molecular weights matching theoretical values (e.g., ~14,200 Da for G4), confirming complete layer-by-layer assembly without significant inter-generational contamination. This technique is particularly effective in acidic buffers ( ~3) to protonate amines and expand the structure for better resolution.

Biocompatibility and Toxicity

In Vitro Toxicity

Poly(amidoamine) (PAMAM) dendrimers demonstrate significant cytotoxicity in various in vitro cell culture models, with toxicity profiles strongly influenced by dendrimer generation and surface charge density. Cationic amine-terminated PAMAM dendrimers exhibit a generation-dependent increase in cytotoxicity, where higher generations such as G5 are more toxic than lower ones like G3, primarily due to the greater number of protonated amine groups that amplify electrostatic interactions with cellular structures. This trend is evident in half-maximal inhibitory concentration (IC50) values, which decrease with increasing generation, highlighting the enhanced potency of higher generations in melanoma cells. MTT assays, commonly used to assess cell viability, have shown that G4 PAMAM maintains moderate viability in human fibroblast and epithelial cell lines at typical concentrations, though viability drops sharply at higher concentrations or with elevated generations. The mechanisms underlying PAMAM-induced cytotoxicity involve multiple cellular disruptions triggered by the dendrimers' cationic nature. Primary interactions occur between the positively charged dendrimer surface and negatively charged cell membranes, leading to membrane destabilization, increased permeability, and eventual lysis. Additionally, PAMAM dendrimers promote the intracellular generation of reactive oxygen species (ROS), resulting in oxidative stress that damages proteins, lipids, and DNA, thereby inducing apoptosis or necrosis in affected cells. Lysosomal impairment is another key pathway, where dendrimers accumulate in lysosomes, causing rupture and release of hydrolytic enzymes into the cytoplasm, further exacerbating cellular toxicity. These effects are dose-dependent and more pronounced in higher-generation dendrimers due to their compact structure and higher charge density facilitating efficient cellular uptake via endocytosis. Hemolytic activity represents a specific aspect of PAMAM cytotoxicity observed in red blood cell models. Unmodified cationic PAMAM dendrimers induce hemolysis exceeding 10% at concentrations above 100 µg/mL, attributed to direct disruption of erythrocyte membranes through charge-based adsorption and pore formation. This hemolytic potential is generation-dependent, with higher generations showing greater activity, but remains lower than that of branched (PEI) dendrimers under comparable conditions. A study by Albertazzi et al. confirmed the dose- and generation-dependent of PAMAM dendrimers in cells, where G6 dendrimers reduced viability more substantially than G2 or G4 at equivalent concentrations, underscoring the role of surface amine density in modulating toxic responses. Surface modifications, such as , can partially alleviate these toxic effects by shielding cationic groups.

In Vivo Toxicity

In vivo studies of poly(amidoamine) (PAMAM) dendrimers in animal models reveal generation-dependent biodistribution patterns, with smaller generations (G3 and G4, hydrodynamic radius <5 nm) exhibiting rapid renal clearance and minimal tissue retention, while larger generations (G6 and above) show predominant accumulation in the liver and spleen due to their size exceeding the renal filtration threshold. For instance, in tumor-bearing mice administered intravenously, G5.0 hydroxyl-terminated PAMAM demonstrated kidney excretion with up to 150% injected dose per gram in renal tissue at one week post-injection, whereas G6.0 and G7.0 variants accumulated significantly in hepatic tissues (up to 40% dose per gram). PAMAM dendrimers generally exhibit low immunogenicity in animal models for generations up to G7, with no detectable immune responses observed in rabbits or BALB/c mice using immunoprecipitation and ELISA assays, though surface modifications like PEGylation further mitigate potential activation of innate immunity. Intravenous administration at high doses can induce slight pulmonary inflammation, as evidenced by elevated serum angiotensin II levels and transient lung injury in mice and rats following intratracheal delivery of G4-G7 variants, highlighting route-specific risks that inform systemic delivery strategies. Acute toxicity assessments in mice indicate a maximum tolerated dose (MTD) exceeding 500 mg/kg for anionic or hydroxyl-terminated PAMAM via , with no signs of mortality or behavioral abnormalities observed, whereas cationic variants show lower thresholds (30-200 mg/kg) depending on generation and route. Recent studies from the report minimal organ damage, such as reversible liver enzyme elevations and no persistent histopathological changes in kidneys or lungs at doses up to 100 mg/kg intravenously, underscoring the of lower-generation or modified PAMAM for prolonged applications. Human data on PAMAM dendrimers remains limited to preclinical evaluations, with no Phase III clinical trials completed to date; research emphasizes variants engineered for reduced toxicity, such as PEGylated or acetylated forms, to bridge the gap toward clinical translation. As of 2025, human data remains limited to Phase I/II trials for modified PAMAM variants, with no Phase III completions or regulatory approvals reported.

Modifications

Surface Functionalization

Surface functionalization of poly(amidoamine) (PAMAM) primarily targets the abundant terminal primary groups on the dendrimer periphery to mitigate inherent cationic charge-related issues, such as and rapid clearance, while enabling active targeting for biomedical applications. These modifications enhance by reducing nonspecific interactions with biological membranes and proteins, thereby improving the dendrimers' suitability for use. A prominent approach is , where (PEG) chains are covalently attached to surface amines, effectively shielding the positive charge. This charge neutralization minimizes electrostatic interactions that drive in unmodified PAMAM, with studies reporting up to a 5-10-fold decrease in hemolytic and cellular for PEGylated generations 4-5 dendrimers compared to native forms. represents another key modification, involving the reaction of surface amines with to cap them with neutral acetyl groups, which neutralizes charge and reduces by more than 10-fold in Caco-2 cell lines. For targeted delivery, ligands like folic acid or antibodies are conjugated to the dendrimer surface to exploit receptor overexpression on cancer cells, such as folate receptors or tumor-associated antigens. Folic acid conjugation often employs N-hydroxysuccinimide (NHS)-ester activation of its carboxyl group, followed by bond formation with dendrimer amines, achieving selective uptake in folate receptor-positive cells like KB tumor lines. Similarly, antibodies can be linked via NHS-ester chemistry targeting residues, enabling specific binding and internalization in antigen-expressing tumors, as demonstrated with anti-HER2 conjugates on generation 5 PAMAM. Alternative techniques, such as carbodiimide-mediated coupling (e.g., using EDC for folic acid's carboxyl to dendrimer amines), preserve dendrimer integrity while attaching ligands. These surface alterations significantly extend systemic circulation. For instance, promotes the enhanced permeability and retention (EPR) effect, leading to greater tumor accumulation; a 2022 study on PEGylated PAMAM for reported higher intratumoral uptake in xenograft models compared to non-PEGylated variants. Unmodified PAMAM's base , stemming from its high surface charge, is thus substantially alleviated without compromising the dendrimer's core functionality. Recent advances (as of 2025) include the use of half-generation PAMAM dendrimers (G0.5–G3.5) with end-groups to improve anticancer , such as with DACHPtCl2 and 5-FU, by enhancing and reducing toxicity. Additionally, PAMAM dendrimers have been integrated with gold nanoparticles for prolonged circulation and ligand-specific targeting in cancer therapy.

Core and Internal Variations

Core variations in poly(amidoamine) (PAMAM) dendrimers involve replacing the standard (ED) core with alternative diamines to modulate , stability, and responsiveness to environmental stimuli. A prominent example is the use of as the core initiator, which incorporates a bond that renders the dendrimer bioreducible in the presence of intracellular . This design facilitates stimuli-responsive disassembly and controlled release of encapsulated payloads, such as nucleic acids or drugs, in reducing environments like the . Such -core PAMAM dendrimers maintain compatibility with the divergent synthesis approach, involving sequential Michael addition of followed by amidation with the core diamine, with generational purity assessed via ¹H NMR to confirm branch completeness and absence of defects. Although less common, cores derived from hydrophobic diamines, such as those based on bis-phenol A structures, can enhance the and loading capacity for hydrophobic therapeutics by increasing the internal hydrophobicity while preserving the dendritic . These modifications allow for better encapsulation of non-polar molecules within the interior, tuning overall for specific applications. Internal modifications target the tertiary amines within PAMAM branches to optimize pH-dependent behaviors. Quaternization of these amines via introduces permanent positive charges, enhancing electrostatic interactions with nucleic acids and improving and efficiency. This can lead to better endosomal disruption despite potentially reducing the proton sponge effect due to loss of protonatable sites. Reducible cores, such as cystamine-based variants, synergize with internal modifications by promoting disassembly post-endosomal escape; the reduction in the reductive cytosolic milieu (e.g., 2-10 mM ) triggers dendrimer unpacking and payload liberation. For instance, cystamine-core PAMAM dendrimers in siRNA delivery systems exhibit enhanced cytoplasmic release, correlating with superior compared to non-reducible ED-core analogs. These variations collectively expand PAMAM's utility in responsive delivery without altering surface properties, which can be further complemented by targeted functionalizations. Recent developments as of 2025 also include PAMAM-based nanogels for cancer therapy, where dendrimers serve as crosslinkers to create responsive networks for improved drug release, and modifications for CT contrast agents to enable tumor imaging and theranostics.

Applications

Poly(amido) (PAMAM) dendrimers serve as versatile nanocarriers for small molecule drugs and biologics in therapeutic delivery, primarily through two mechanisms: encapsulation within their internal cavities or conjugation to surface groups. Encapsulation leverages the dendrimer's hydrophobic interior to trap poorly soluble drugs, while conjugation enables covalent or electrostatic attachment for stable transport. Additionally, PAMAM dendrimers exploit the enhanced permeability and retention (EPR) effect for passive targeting of tumor tissues, where leaky vasculature allows preferential accumulation in solid tumors. A representative example is the loading of (DOX), an anticancer agent, into generation 4 (G4) PAMAM dendrimers, achieving encapsulation efficiencies of 70-90% via electrostatic interactions under controlled conditions. For targeted delivery, CXCR4-targeted PAMAM dendrimers loaded with DOX have demonstrated greater efficacy compared to free DOX in BT-549 cells due to enhanced cellular uptake. PAMAM dendrimers offer advantages such as pH-responsive controlled release, where interior at endosomal (around 5.5) triggers drug dissociation, achieving up to 75% release in acidic environments versus minimal release at physiological 7.4. They also exhibit superior to liposomes, with lower toxicity profiles and reduced nonspecific protein binding, enhancing stability and tolerability in . Despite promising preclinical results, PAMAM-based systems for anticancer drug delivery remain in preclinical stages, with ongoing trials focused on optimizing targeting and safety; no FDA-approved formulations exist as of 2025.

Gene Therapy

Poly(amidoamine) (PAMAM) dendrimers serve as non-viral vectors for gene therapy by forming polyplexes through electrostatic interactions between their cationic amine groups and the polyanionic phosphate backbone of nucleic acids such as DNA or RNA. Optimal complexation typically occurs at nitrogen-to-phosphate (N/P) ratios of 5-10, where the resulting polyplexes exhibit sizes of approximately 100-200 nm, facilitating cellular uptake while protecting the genetic cargo from nuclease degradation. These nanoscale structures condense the nucleic acids into compact, stable forms suitable for delivery. In transfection processes, PAMAM dendrimers leverage the proton sponge effect, where their internal tertiary amines buffer endosomal , leading to osmotic swelling and endosomal escape for cytoplasmic release of the nucleic acids. Generation 5 (G5) PAMAM dendrimers, in particular, demonstrate high efficiency, achieving levels comparable to 2000 in HEK293 cells at N/P ratios around 20, with expression rates exceeding 50% in optimized PEG-conjugated variants. Representative applications include siRNA delivery for ; for instance, a 2022 study using glutathione-sensitive PAMAM-siRNA conjugates targeting GFP in models achieved approximately 30-40% knockdown in tumor-associated macrophages, correlating with reduced tumor progression in preclinical orthotopic models. Similarly, PAMAM dendrimers have facilitated CRISPR-Cas9 delivery in preclinical settings, such as phenylboronic acid-modified variants enabling efficient ribonucleoprotein uptake and in lines with minimal off-target effects. Key advantages of PAMAM-based systems include their non-viral nature, which confers lower immunogenicity compared to viral vectors, and the potential for activation via mild heat treatment (e.g., 40°C for 12 hours) to enhance dendrimer flexibility and transfection efficiency by up to several-fold in EGFR-overexpressing cells. These properties position PAMAM as a versatile platform for therapeutic gene modulation.

Emerging Biomedical Uses

Recent advancements in poly(amidoamine) (PAMAM) dendrimers have expanded their utility beyond traditional drug and gene delivery into diagnostic imaging applications, particularly as contrast agents for magnetic resonance imaging (MRI). In a 2022 study, PAMAM dendrimer-based metal-free radical contrast agents demonstrated enhanced tumor detection in glioblastoma-bearing mice, achieving a twofold increase in the tumor-to-normal brain signal intensity ratio compared to the commercial Gd-based agent Gd-DOTA. This improvement stems from the dendrimers' ability to provide prolonged circulation and targeted accumulation in tumor tissues, offering superior relaxivity and reduced toxicity relative to low-molecular-weight Gd chelates. Such developments highlight PAMAM's potential for precise, non-invasive cancer diagnostics. PAMAM dendrimers have also emerged in biosensor technologies, notably for electrochemical detection of biomarkers like glucose. A 2015 review underscores how PAMAM facilitates amplified in these sensors, enabling higher sensitivity for glucose monitoring in physiological samples through multilayer immobilization of enzymes and electrocatalysts. This dendrimer-mediated enhancement allows for rapid, point-of-care detection with improved limits of detection, making it suitable for and real-time health monitoring. In novel therapeutic contexts, PAMAM dendrimers show promise for antibacterial applications and targeted interventions. For instance, PAMAM-antibiotic complexes, including those with silver nanoparticles, exhibit potent activity suitable for by promoting sustained release and reducing bacterial resistance. Similarly, in 2023 research, angiopep-2-grafted PEGylated PAMAM dendrimers enabled blood-brain barrier crossing for targeting, enhancing efficiency to tumor sites while minimizing off-target effects in murine models. Emerging trends involve hybrid PAMAM constructs for theranostics and environmental sensing. PAMAM-graphene oxide hybrids integrate and capabilities, leveraging the dendrimer's functionalization for multimodal cancer detection and treatment. Additionally, PAMAM-based materials have been applied in environmental sensing, with 2022 studies demonstrating their efficacy in heavy metal ion removal from aqueous solutions via and adsorption, achieving high removal capacities for pollutants like Pb²⁺ and Cd²⁺.

References

  1. https://www.dendritech.com/pamam.html
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6269116/
  3. https://www.sciencedirect.com/science/article/pii/S2468519417302033
  4. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/poly-amidoamine
  5. https://pubs.acs.org/doi/10.1021/ma00163a029
  6. https://jbioleng.biomedcentral.com/articles/10.1186/s13036-022-00298-5
  7. https://www.dendritech.com/images/IDS_6_scheibert.pdf
  8. http://web.mit.edu/course/10/10.569/www/Tomaliadendrhistory.pdf
  9. https://www.nature.com/articles/pj198510
  10. https://www.dendritech.com/about.html
  11. https://www.sciencedirect.com/science/article/abs/pii/S1359644601017573
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC6723213/
  13. https://pubs.rsc.org/en/content/articlelanding/2023/sd/d3sd00101f
  14. https://www.tandfonline.com/doi/full/10.1080/09205063.2025.2497623
  15. https://doi.org/10.1016/j.trac.2022.116810
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC3624701/
  17. https://www.sciencedirect.com/science/article/pii/S000925092300221X
  18. https://pubs.acs.org/doi/10.1021/acsomega.5c07827
  19. https://apps.dtic.mil/sti/tr/pdf/ADA359423.pdf
  20. https://www.sciencedirect.com/science/article/pii/S2666978125000236
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC6225146/
  22. https://apps.dtic.mil/sti/tr/pdf/ADA346880.pdf
  23. https://cdnsciencepub.com/doi/10.1139/cjc-2017-0108
  24. https://etd.ohiolink.edu/acprod/odb_etd/ws/send_file/send?accession=ucin998323664&disposition=inline
  25. https://www.sciencedirect.com/science/article/abs/pii/S0040402014017967
  26. https://pubs.acs.org/doi/10.1021/ma052526f
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC3501731/
  28. https://www.sciencedirect.com/science/article/pii/S0001868618301350
  29. https://www.mdpi.com/2073-4360/4/1/600
  30. https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/mas.21876
  31. https://www.sciencedirect.com/science/article/abs/pii/S0032386198002687
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC3775363/
  33. https://www.sciencedirect.com/science/article/abs/pii/S0887233309002811
  34. https://pubmed.ncbi.nlm.nih.gov/22633897/
  35. https://www.sciencedirect.com/science/article/abs/pii/S0041008X10003017
  36. https://onlinelibrary.wiley.com/doi/abs/10.1002/jbm.b.31558
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC3476841/
  38. https://www.mdpi.com/1999-4923/14/6/1292
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC3860365/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC9409959/
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC9230513/
  42. https://pubs.acs.org/doi/10.1021/bc800125u
  43. https://pubs.rsc.org/en/content/articlehtml/2023/sm/d2sm01698b
  44. https://www.researchgate.net/publication/305364150_PEGylated_PAMAM_Dendrimers_Enhancing_Efficacy_and_Mitigating_Toxicity_for_Effective_Anticancer_Drug_and_Gene_Delivery
  45. https://pubmed.ncbi.nlm.nih.gov/17960872/
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC6414888/
  47. https://wires.onlinelibrary.wiley.com/doi/abs/10.1002/wnan.1951
  48. https://www.mdpi.com/1420-3049/30/9/2024
  49. https://www.sciencedirect.com/science/article/abs/pii/S0040402003004307
  50. https://pubs.acs.org/doi/10.1021/bc034095g
  51. https://link.springer.com/article/10.1007/s13233-012-0164-5
  52. https://www.tandfonline.com/doi/full/10.2217/nnm-2024-0079
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC7765183/
  54. https://www.mdpi.com/1999-4923/17/7/927
  55. https://www.mdpi.com/1999-4923/15/12/2740
  56. https://pmc.ncbi.nlm.nih.gov/articles/PMC2758109/
  57. https://pubs.acs.org/doi/10.1021/acsami.2c13129
  58. https://onlinelibrary.wiley.com/doi/full/10.1002/bmm2.12025
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC3428245/
  60. https://pubs.acs.org/doi/10.1021/acs.biomac.2c00088
  61. https://www.researchgate.net/publication/311649889_Dendrimers_based_electrochemical_biosensors
  62. https://www.researchgate.net/publication/231712365_Dendrimer-Silver_Complexes_and_Nanocomposites_as_Antimicrobial_Agents
  63. https://pubs.acs.org/doi/10.1021/acsbiomaterials.3c00263
  64. https://www.frontiersin.org/journals/chemistry/articles/10.3389/fchem.2022.814643/full
Add your contribution
Related Hubs
Contribute something
User Avatar
No comments yet.